Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease
Condition: GERD Interventions: Drug: JP-1366; Drug: JP-1366 placebo; Drug: Esomeprazole 40mg; Drug: Esomeprazole placebo Sponsor: Jeil Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acid Reflux | Clinical Trials | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Research